Confirmation of the utility of the Wells' Score for pulmonary embolism in patients with sickle cell disease

J Thromb Thrombolysis. 2022 Jul;54(1):193-196. doi: 10.1007/s11239-022-02656-y. Epub 2022 Apr 19.

Authors

Jori E May¹, Steven D Lauzon², Richard C Godby³, Julie Kanter⁴

Affiliations

¹ Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA. jemay@uabmc.edu.
² Eli Lilly and Company, Indianapolis, IN, USA.
³ Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
⁴ Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA.

PMID: 35438375
DOI: 10.1007/s11239-022-02656-y

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / diagnosis
Fibrin Fibrinogen Degradation Products
Humans
Pulmonary Embolism* / diagnosis
Pulmonary Embolism* / etiology

Substances

Fibrin Fibrinogen Degradation Products

Grants and funding